In a mouse model of TNBS colitis, intervention with the CXCR2 inhibitor SB225002 significantly reduced tissue damage, inflammation and levels of IL‐1β, MIP‐2, iNOS and KC, thereby improving survival.54 Here, CXCL2 is linked to colitis.